Organ Transplant Clinical Trial
Official title:
Randomized Trial to Compare the SherpaPak™ Device vs Cold Storage of Donor Hearts in Transplantation: A Pilot Study
The Investigator's are doing this study to see which method of organ preservation leads to better outcomes for donated hearts. There are two methods of organ preservation. The first method is the use of cold storage. With this method, the donor heart is stored in preservation fluid within bags that are then placed on ice and transported in a cooler. This is the usual method for transporting donor hearts. This is also known as "standard of care." The second method is the use of the SherpaPak™ Cardiac Transport System. With this method, the donor heart is kept at a steady, consistent temperature throughout transportation. This method is not typically used for transporting donor hearts. The study will include up to 20 people in total.
This is a randomized study and has 2 study groups. Participants will be randomly assigned to a group in a 1:1 ratio. - 50% chance of receiving a donor heart using the SherpaPak™ method, or - 50% chance of receiving a donor heart using the cold storage method. The research team will analyze data from the medical records from the heart transplant and clinic visits up to 30 days after the heart transplant. Participants will be in the study for about 30 days. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03938324 -
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions
|
N/A | |
| Recruiting |
NCT05462041 -
DCD IIT: Evaluating the Safety of Utilizing Donor Hearts From Donation After Circulatory Death (DCD) Donors
|
N/A | |
| Completed |
NCT02729142 -
Bone Microarchitecture in the Transplant Patient
|
N/A | |
| Completed |
NCT00213265 -
Safety and Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Children Receiving Solid Organ Transplants
|
Phase 3 | |
| Withdrawn |
NCT05157997 -
Transplantation of Deceased Donors With COVID-19 Into COVID-19 Negative Recipients Utilizing Casirivimab and Imdevimab Antibody Cocktail
|
Phase 1 | |
| Not yet recruiting |
NCT05732922 -
ORCHARD- Optimising Home Assessment of Rural Patients
|
N/A | |
| Recruiting |
NCT05595837 -
Immune Registry for Organ Transplantation From COVID Positive Donors.
|
||
| Completed |
NCT05194306 -
PERTRIAL - Perla® Preservation Solution
|
N/A | |
| Completed |
NCT00367809 -
Wellness Interventions After Transplant Study
|
Phase 3 | |
| Recruiting |
NCT05884736 -
Confirming Permanent Lack of Blood Flow to the Brain During A-NRP DCC Organ Transplant
|